Patents by Inventor Sharon Real

Sharon Real has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody formulations and uses thereof
    Patent number: 10195281
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: February 5, 2019
    Assignee: Tracon Pharmaceuticals, Inc.
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
  • Antibody Formulations and Uses Thereof
    Publication number: 20180311359
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 1, 2018
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
  • Antibody Formulations and Uses Thereof
    Publication number: 20150209430
    Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.
    Type: Application
    Filed: September 5, 2013
    Publication date: July 30, 2015
    Applicant: Tracon Pharmaceuticals, Inc.
    Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer